Advances of artificial intelligence in clinical application and scientific research of neuro-oncology: Current knowledge and future perspectives.

Journal: Critical reviews in oncology/hematology
PMID:

Abstract

Brain tumors refer to the abnormal growths that occur within the brain's tissue, comprising both primary neoplasms and metastatic lesions. Timely detection, precise staging, suitable treatment, and standardized management are of significant clinical importance for extending the survival rates of brain tumor patients. Artificial intelligence (AI), a discipline within computer science, is leveraging its robust capacity for information identification and combination to revolutionize traditional paradigms of oncology care, offering substantial potential for precision medicine. This article provides an overview of the current applications of AI in brain tumors, encompassing the primary AI technologies, their working mechanisms and working workflow, the contributions of AI to brain tumor diagnosis and treatment, as well as the role of AI in brain tumor scientific research, particularly in drug innovation and revealing tumor microenvironment. Finally, the paper addresses the existing challenges, potential solutions, and the future application prospects. This review aims to enhance our understanding of the application of AI in brain tumors and provide valuable insights for forthcoming clinical applications and scientific inquiries.

Authors

  • Yankun Zhan
    First People's Hospital of Linping District; Linping Campus, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 311100, China.
  • Yanying Hao
    First People's Hospital of Linping District; Linping Campus, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 311100, China.
  • Xiang Wang
    Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Duancheng Guo
    Cancer Institute, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: guoduancheng@shca.org.cn.